American Society of Hematology

Latest stories

4h
Business Wire
Gilead Sciences maakt financiële resultaten van het vierde kwartaal en van het gehele jaar 2015 bekendFOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD)
Gilead Sciences maakt financiële resultaten van het vierde kwartaal en van het gehele jaar 2015 bekend
Business Wire / Posted 4 hours ago
FOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag haar bedrijfsresultaten bekendgemaakt voor het vierde kwartaal en het gehele jaar 2015. De totale opbrengsten voor het vierde kwartaal van 2015 waren $ 8,5... Read more
26 related stories
2d
San Antonio Express-News
Why Juno Therapeutics Dropped by 10% on TuesdayWhat: According to data provided by S&P Capital IQ, the clinical-stage cancer i
Why Juno Therapeutics Dropped by 10% on Tuesday
San Antonio Express-News / Posted 2 days ago
What: According to data provided by S&P Capital IQ, the clinical-stage cancer immunotherapy company Juno Therapeutics shed 10% of its value on moderately high volume yesterday. Juno's shares are now trading at 52-week lows and are currently down a... Read more
4d
San Antonio Express-News
bluebird bio Inc. Takes FlightWhat:bluebird bio ended up 10.6% on Monday in a surge that didn't seem to have
bluebird bio Inc. Takes Flight
San Antonio Express-News / Posted 4 days ago
What:bluebird bio ended up 10.6% on Monday in a surge that didn't seem to have any news behind it. So what: Double digit moves usually don't happen by accident, but keep in mind that bluebird bio was at this level as recently as last Wednesday. Like... Read more
9d
Business Wire
Biogen 2015 Revenues Increase 11% to $10.8 BillionCAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported fu
Biogen 2015 Revenues Increase 11% to $10.8 Billion
Business Wire / Posted 9 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter 2015 results, including full year revenues of $10.8 billion, an 11% increase versus 2014. Full year 2015 Non-GAAP diluted earnings per share... Read more
17d
Business Wire
NOXXON Pharma Hosts Key Opinion Leader SymposiumBERLIN--(BUSINESS WIRE)--NOXXON Pharma AG (“NOXXON” or the “Company”), a clinic
NOXXON Pharma Hosts Key Opinion Leader Symposium
Business Wire / Posted 17 days ago
BERLIN--(BUSINESS WIRE)--NOXXON Pharma AG (“NOXXON” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on cancer treatment development, today announces that the Company hosted a Key Opinion Leader symposium focused on... Read more
18d
The Florida Times-Union
'Sickle cell is not going to stop me,' boy says getting ready for Wolfson Children's ChallengeTurod Vincent was first hospitalized when he was 4 months old. Sickle cell ane
'Sickle cell is not going to stop me,' boy says getting ready for Wolfson Children's Challenge
The Florida Times-Union / Posted 18 days ago
Turod Vincent was first hospitalized when he was 4 months old. Sickle cell anemia — the most common form of an inherited blood disorder that can cause pain, infections and organ damage — sent him back to the hospital four or five times a year until... Read more
29d
TheStreet.com
2016 Biotech Stock Prediction: It's going to be a bummer year, folks2016 will be a difficult year for biotech stocks. I'm only making one big pred
2016 Biotech Stock Prediction: It's going to be a bummer year, folks
TheStreet.com / Posted 29 days ago
2016 will be a difficult year for biotech stocks. I'm only making one big prediction this year: The five-year party which saw biotech stocks outperform the broader markets comes to an end in 2016. Good biotech science marches on but negative fund... Read more
30d
FOX News
Experts support call for lower cancer drug pricesA group of 118 leading cancer experts have developed a list of proposals design
Experts support call for lower cancer drug prices
FOX News / Posted 30 days ago
A group of 118 leading cancer experts have developed a list of proposals designed to reduce the cost of cancer drugs, and support a grassroots patient protest movement to pressure drug companies to charge what they deem a fair value for... Read more
1m
News-Medical-Net
Hydroxyurea could be a viable option for children with sickle cell diseaseA national sickle cell disease study involving Medical University of South Caro
Hydroxyurea could be a viable option for children with sickle cell disease
News-Medical-Net / Posted a month ago
A national sickle cell disease study involving Medical University of South Carolina researchers found that for some children with sickle cell disease, the drug hydroxyurea is as effective as blood transfusions to reduce blood flow speeds in the... Read more
m
Business Wire
Asana BioSciences Appoints Dr. Kapil Dhingra to its Oncology Scientific Advisory BoardBRIDGEWATER, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC today announced that
Asana BioSciences Appoints Dr. Kapil Dhingra to its Oncology Scientific Advisory Board
Business Wire / Posted 1 months ago
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC today announced that Kapil Dhingra, M.D., has been appointed to its oncology scientific advisory board (SAB). Dr. Dhingra is the former head of Roche Oncology Clinical Development and the... Read more

People in this news